Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.
Research Interests

Papers共 74 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
First-in-human Safety, Tolerability, Pharmacokinetics and Pilot Food-Effect Study of the Candidate Antimalarial Compound MMV367
Andrea Kuemmerle,Nand Singh, Denis Gossen, Annick Janin,Raman Sharma,Anthony Cahn,Rachel A Gibson, Somasekhara R Menakuru, Erin Lambourne, Tom Dove,Francisco-Javier Gamo, Laura Sanz, Benoit Bestgen,Stephan Chalon
British journal of clinical pharmacologyno. 6 (2025): 1821-1833
Cited0Views0WOSBibtex
0
0
Adjunctive Ruxolitinib Attenuates Inflammation and Enhances Antiparasitic Immunity in Human Volunteers Experimentally Infected with Plasmodium Falciparum
Rebecca Webster, Damian A. Oyong, Azrin N. Abd-Rahman, Adam J. Potter, Reena Mukhiya,Nischal Sahai, Indika Leelasena, Eniko Ujvary, Sue Mathison, Dean W. Andrew, Luzia Bukali,Fabian de Labastida Rivera, Jessica Engel,Megan S.F. Soon, Teija Frame, Julianne Hamelink,Mayimuna Nalubega, Nicholas L. Dooley, Jessica R. Loughland, Tran Nguyen,Yael Rosenberg-Hasson, Sofia Maysel-Auslender,Natalia Sigal, Kira Foygel, Jeremy Gower, Jenny Peters, Ria Woo, Fiona Amante,Timothy N.C. Wells,Stephan Chalon,Joerg J. Moehrle,James S. McCarthy,Geoffrey W. Birrell,Michael D. Edstein, Michael Leipold,Gerlinde Obermoser,Holden Maecker, Christian R. Engwerda,Bridget E. Barber,Michelle J. Boyle
medrxiv（2025）
Cited0Views0Bibtex
0
0
Load More
Author Statistics

#Papers: 74

#Citation: 1887

H-Index: 22

G-Index: 43

Sociability: 6

Diversity: 2

Activity: 10

  • 合作者
  • 学生
  • 导师
No result temporarily, you can search similar Scholar with the same research interest
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn